Literature DB >> 29529635

What Is the Effect of High-dose Radiation on Bone in Patients With Sacral Chordoma? A CT Study.

Olivier van Wulfften Palthe1, Kyung-Wook Jee, Jos A M Bramer, Francis J Hornicek, Yen-Lin E Chen, Joseph H Schwab.   

Abstract

BACKGROUND: Effects of high-dose radiation using protons and photons on bone are relatively unexplored, but high rates of insufficiency fractures are reported, and the causes of this are incompletely understood. Imaging studies with pre- and postradiation scans can help one understand the effect of radiation on bone. QUESTIONS/PURPOSES: The purpose of this study was to assess the effects of high-dose radiation on the trabecular density of bone in the sacrum using CT-derived Hounsfield units (HU).
METHODS: Between 2009 and 2015, we treated 57 patients (older then 18 years) with sacral chordoma. Fourteen (25%) of them were treated with radiation only. The general indication for this approach is inoperability resulting from tumor size. Forty-two (74%) patients were treated with transverse sacral resections and high-dose radiotherapy (using either protons or photons or a combination) before surgery and after surgery. During this time period, our indication for this approach generally was symptomatic sacral chordoma in which resection would prevent further growth and reasonable sacrifice of nerve roots was possible. Of those patients, 21 (50%) had CT scans both before and after radiation treatment. We used HU as a surrogate for bone density. CT uses HU to derive information on tissue and bone quantity. A recent study presented reference HU values for normal (mean 133 ± 38 HU), osteoporotic (101 ± 25 HU), and osteopenic bone (79 ± 32 HU). To adjust for scanning protocol-induced changes in HU, we calculated the ratio between bone inside and outside the radiation field rather than using absolute values. To assess the effect of radiation, we tested whether there was a difference in ratio (sacrum/L1) before and after radiation. A control measurement was performed (L2/L1) and also tested for a difference before and after radiation. Statistical analyses were performed using the paired t-test.
RESULTS: The effects of radiation appeared confined to the intended field, because the bone density outside the treated field was not observed to decrease. The ratio of HU (a surrogate for bone density) in L2 relative to L1 did not change after radiotherapy (preradiation mean: 0.979 ± 0.009, postradiation mean: 0.980 ± 0.009, mean difference outside the radiation field: -0.001, 95% confidence interval [CI], -0.009 to 0.007, p = 0.799). The ratio of HU within the radiation field relative to L1 decreased after radiotherapy (preradiation mean: 0.895 ± 0.050, postradiation mean: 0.658 ± 0.050, mean difference inside the radiation field: 0.237, 95% CI, 0.187-0.287, p < 0.001), suggesting the bone density stayed the same outside the radiation field but decreased inside the radiation field.
CONCLUSIONS: Trabecular bone density decreased after high-dose radiation therapy in a small group of patients with sacral chordoma. High-dose radiation is increasingly gaining acceptance for treating sacral malignancies; further long-term prospective studies using calibrated CT scanners and preferably bone biopsies are needed. LEVEL OF EVIDENCE: Level IV, therapeutic study.

Entities:  

Mesh:

Year:  2018        PMID: 29529635      PMCID: PMC6260039          DOI: 10.1007/s11999.0000000000000063

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  42 in total

Review 1.  The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.

Authors:  Glen M Blake; Ignac Fogelman
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

2.  Sacral chordoma: 40-year experience at a major cancer center.

Authors:  J E York; A Kaczaraj; D Abi-Said; G N Fuller; J M Skibber; N A Janjan; Z L Gokaslan
Journal:  Neurosurgery       Date:  1999-01       Impact factor: 4.654

3.  Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.

Authors:  Reiko Imai; Tadashi Kamada; Nobuhito Araki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-08       Impact factor: 7.038

4.  Proton therapy at Harvard.

Authors:  J E Munzenrider; M Austin-Seymour; P J Blitzer; R Gentry; M Goitein; E S Gragoudas; K Johnson; A M Koehler; P McNulty; G Moulton
Journal:  Strahlentherapie       Date:  1985-12

5.  Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Authors:  Johann Sebastian de Bono; Stephane Oudard; Mustafa Ozguroglu; Steinbjørn Hansen; Jean-Pascal Machiels; Ivo Kocak; Gwenaëlle Gravis; Istvan Bodrogi; Mary J Mackenzie; Liji Shen; Martin Roessner; Sunil Gupta; A Oliver Sartor
Journal:  Lancet       Date:  2010-10-02       Impact factor: 79.321

Review 6.  Advanced-technology radiation therapy for bone sarcomas.

Authors:  Samir Patel; Thomas F DeLaney
Journal:  Cancer Control       Date:  2008-01       Impact factor: 3.302

7.  Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Authors:  Polina Osler; Miriam A Bredella; Kathryn A Hess; Stein J Janssen; Christine J Park; Yen Lin Chen; Thomas F DeLaney; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2015-09-23       Impact factor: 4.176

8.  Review of photon and proton radiotherapy for skull base tumours.

Authors:  Piero Fossati; Andrea Vavassori; Letizia Deantonio; Eleonora Ferrara; Marco Krengli; Roberto Orecchia
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-16

9.  Computed tomography-based finite element analysis predicts failure loads and fracture patterns for vertebral sections.

Authors:  M J Silva; T M Keaveny; W C Hayes
Journal:  J Orthop Res       Date:  1998-05       Impact factor: 3.494

10.  Treatment of femoral fractures after irradiation.

Authors:  P P Lin; P J Boland; J H Healey
Journal:  Clin Orthop Relat Res       Date:  1998-07       Impact factor: 4.176

View more
  4 in total

1.  Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Authors:  Matthew T Houdek; Peter S Rose; Mario Hevesi; Joseph H Schwab; Anthony M Griffin; John H Healey; Ivy A Petersen; Thomas F DeLaney; Peter W Chung; Michael J Yaszemski; Jay S Wunder; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter C Ferguson
Journal:  J Surg Oncol       Date:  2019-02-07       Impact factor: 3.454

2.  Fingolimod inhibits proliferation and epithelial-mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling.

Authors:  Jiaqi Wang; Wenhao Hu; Xiaowen Du; Ying Sun; Shuai Han; Guanjun Tu
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

3.  The Effect of High-Dose Radiation Therapy on Healthy Vertebral Bone Density.

Authors:  Ravi Gaddipati; Garrett L Jensen; Gregory Swanson; Kendall Hammonds; Andrew Morrow
Journal:  Cureus       Date:  2022-02-24

4.  Bone Density Changes Following Radiotherapy to Vertebral Metastases.

Authors:  Garrett L Jensen; Ravi Gaddipati; Kendall P Hammonds; Andrew Morrow; Gregory P Swanson
Journal:  Cureus       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.